Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Viral Transfer Technology
  • Published:

Tri-iodothyronine and a deleted form of hepatocyte growth factor act synergistically to enhance liver proliferation and enable in vivo retroviral gene transfer via the peripheral venous system

Gene Therapy volume 7, pages 784–789 (2000)Cite this article

Abstract

Retroviral vectors integrate into the target cell genome in a stable manner and therefore offer the potential for permanent correction of the genetic diseases that affect the liver. These vectors, however, usually require cell division to occur in order to allow provirus entry into the nucleus. We have explored clinically acceptable methods to improve the efficiency of retroviral gene transfer to the liver, which avoid the need for liver damage. Tri-iodothyronine (T3) and recombinant hepatocyte growth factor have previously been used to induce hepatocyte proliferation in rat livers and allow in vivo retroviral gene transfer. We investigated the combined effects of these growth factors, with their differing mechanisms of action, on hepatocyte proliferation in vivo and assessed their effectiveness in priming cells for retroviral gene transfer. During the phase of hepatocyte proliferation retrovirus was administered via either the portal or tail vein. Acting synergistically, T3 and a truncated form of recombinant hepatocyte growth factor (dHGF) induced 30% of hepatocytes in normal rat liver to enter DNA synthesis at 24 h. This increased proliferation enabled the liver to be transduced in vivo by retroviral vectors via either the portal or peripheral venous system, achieving transduction efficiencies of 6.9 ± 1.6% and 4.3 ± 0.4% respectively. Thus, the liver can be simply and conveniently transduced in vivo with integrating vectors, introduced via the peripheral venous system during a wave of growth factor-induced proliferation, pointing the way to clinically applicable gene transfer techniques.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  1. Horsthemke B et al. Identification of a deletion in the low density lipoprotein (LDL) receptor gene in a patient with familial hypercholesterolaemia Hum Genet 1985 71: 75–78

    Article  CAS  PubMed  Google Scholar 

  2. Asarian J, Archibald RW, Lieberman J . Childhood cirrhosis associated with alpha-1-antitrypsin deficiency. A genetic, biochemical, and morphologic study J Pediatr 1975 86: 844–850

    Article  CAS  PubMed  Google Scholar 

  3. Clarke DJ et al. Genetic defects of the UDP-glucuronosyltransferase-1 (UGT1) gene that cause familial non-haemolytic unconjugated hyperbilirubinaemias Clinica Chimica Acta 1997 266: 63–74

    Article  CAS  Google Scholar 

  4. Miller AD, Buttimore C . Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production Mol Cell Biol 1998 6: 2895–2902

    Article  Google Scholar 

  5. Bieniasz PD, Weiss RA, McClure MO . Cell cycle dependence of foamy retrovirus infection J Virol 1995 69: 7295–7299

    CAS  PubMed  PubMed Central  Google Scholar 

  6. Andreadis S, Fuller AO, Palsson BO . Cell cycle dependence of retroviral transduction: an issue of overlapping time scales Biotechnol Bioengineer 1998 58: 272–281

    Article  CAS  Google Scholar 

  7. Knaan Shanzer S, Valerio D, van Beusechem VW . Cell cycle state, response to hemopoietic growth factors and retroviral vector-mediated transduction of human hemopoietic stem cells Gene Therapy 1996 3: 323–333

    CAS  PubMed  Google Scholar 

  8. Kafri T et al. A packaging cell line for lentivirus vectors J Virol 1999 73: 576–584

    CAS  PubMed  PubMed Central  Google Scholar 

  9. Ferry N et al. Retroviral-mediated gene transfer into hepatocytes in vivo Proc Natl Acad Sci USA 1991 88: 8377–8381

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Rettinger SD et al. In vivo hepatocyte transduction with retrovirus during in-flow occlusion J Surg Res 1993 54: 418–425

    Article  CAS  PubMed  Google Scholar 

  11. Branchereau S, Calise D, Ferry N . Factors influencing retroviral-mediated gene transfer into hepatocytes in vivo Hum Gene Ther 1994 5: 803–808

    Article  CAS  PubMed  Google Scholar 

  12. Themis M et al. Enhanced in vitro and in vivo gene delivery using cationic agent complexed retrovirus vectors Gene Therapy 1998 5: 1180–1186

    Article  CAS  PubMed  Google Scholar 

  13. Bowling WM et al. Portal branch occlusion safely facilitates in vivo retroviral vector transduction of rat liver Hum Gene Ther 1996 7: 2113–2121

    Article  CAS  PubMed  Google Scholar 

  14. Lieber A et al. Adenovirus-mediated urokinase gene transfer induces liver regeneration and allows for efficient retrovirus transduction of hepatocytes in vivo Proc Natl Acad Sci USA 1995 92: 6210–6214

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Lieber A et al. A modified urokinase plasminogen activator induces liver regeneration without bleeding Hum Gene Ther 1995 6: 1029–1037

    Article  CAS  PubMed  Google Scholar 

  16. Forbes SJ et al. Retroviral gene transfer to the liver in vivo during tri-iodothyronine induced hyperplasia Gene Therapy 1998 5: 552–555

    Article  CAS  PubMed  Google Scholar 

  17. Bosch A et al. Proliferation induced by keratinocyte growth factor enhances in vivo retroviral-mediated gene transfer to mouse hepatocytes J Clin Invest 1996 98: 2683–2687

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Bosch A et al. Effects of keratinocyte and hepatocyte growth factor in vivo: implications for retrovirus-mediated gene transfer to liver Hum Gene Ther 1998 9: 1747–1754

    Article  CAS  PubMed  Google Scholar 

  19. Kosai KI et al. Retrovirus-mediated in vivo gene transfer to the replicating liver using recombinant hepatocyte growth factor without liver injury or partial hepatectomy Hum Gene Ther 1998 9: 1293–1301

    Article  CAS  PubMed  Google Scholar 

  20. Patijn GA et al. Hepatocyte growth factor induces hepatocyte proliferation in vivo and allows for efficient retroviral-mediated gene transfer in mice Hepatology 1998 28: 707–716

    Article  CAS  PubMed  Google Scholar 

  21. Cosset FL et al. High-titer packaging cells producing recombinant retroviruses resistant to human serum J Virol 1995 69: 7430–7436

    CAS  PubMed  PubMed Central  Google Scholar 

  22. Kotin RM et al. Site-specific integration by adeno-associated virus Proc Natl Acad Sci USA 1997 87: 2211–2215

    Article  Google Scholar 

  23. Canzanelli AD et al. Control of liver regeneration and nucleic acid content by the thyroid: with observations on the effects of pyrimidines Am J Physiol 1949 157: 225–229

    Article  CAS  PubMed  Google Scholar 

  24. Francavilla A et al. Hepatocyte proliferation and gene expression induced by triiodothyronine in vivo and in vitro Hepatology 1994 20: 1237–1241

    CAS  PubMed  Google Scholar 

  25. Kitraki E, Philippidis H, Stylianopoulou F . Hormonal control of insulin-like growth factor-II gene expression in the rat liver J Mol Endocrinol 1992 9: 131–136

    Article  CAS  PubMed  Google Scholar 

  26. Angervo M et al. Tri-iodothyronine and cycloheximide enhance insulin-like growth factor-binding protein-1 gene expression in human hepatoma cells J Mol Endocrinol 1993 10: 7–13

    Article  CAS  PubMed  Google Scholar 

  27. Hudig F, Bakker O, Wiersinga WM . Tri-iodothyronine prevents the amiodarone-induced decrease in the expression of the liver low-density lipoprotein receptor gene J Endocrinol 1997 152: 413–421

    Article  CAS  PubMed  Google Scholar 

  28. Demori I et al. Tri-iodothyronine increases insulin-like growth factor binding protein-4 expression in rat hepatocytes J Endocrinol 1997 154: 155–165

    Article  CAS  PubMed  Google Scholar 

  29. Oinonen T, Lindros KO . Hormonal regulation of the zonated expression of cytochrome P-450 3A in rat liver Biochem J 1995 309: 55–61

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Strain AJ et al. Native and recombinant human hepatocyte growth factors are highly potent promoters of DNA synthesis in both human and rat hepatocytes J Clin Invest 1991 87: 1853–1857

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Stolz DB, Michalopoulos GK . Comparative effects of hepatocyte growth factor and epidermal growth factor on motility, morphology, mitogenesis, and signal transduction of primary rat hepatocytes J Cell Biochem 1994 55: 445–464

    Article  CAS  PubMed  Google Scholar 

  32. Gherardi E et al. Hepatocyte growth factor/scatter factor (HGF/SF), the c-met receptor and the behaviour of epithelial cells Symp Soc Exp Biol 1993 47: 163–181

    CAS  PubMed  Google Scholar 

  33. Weidner KM et al. Properties and functions of scatter factor/hepatocyte growth factor and its receptor c-met Am J Respir Cell Mol Biol 1993 8: 229–237

    Article  CAS  PubMed  Google Scholar 

  34. Mizuno K, Nakamura T . Molecular characteristics of HGF and the gene, and its biochemical aspects EXS 1993 65: 1–29

    CAS  PubMed  Google Scholar 

  35. Zarnegar R et al. Expression of hepatocyte growth factor mRNA in regenerating rat liver after partial hepatectomy Biochem Biophys Res Commun 1991 177: 559–565

    Article  CAS  PubMed  Google Scholar 

  36. Shima N et al. Hepatocyte growth factor and its variant with a deletion of five amino acids are distinguishable in their biological activity and tertiary structure Biochem Biophys Res Commun 1994 200: 808–815

    Article  CAS  PubMed  Google Scholar 

  37. Uematsu Y et al. Effective administration route for the deleted form of hepatocyte growth factor to exert its pharmacological effects J Pharm Sci 1999 88: 131–135

    Article  CAS  PubMed  Google Scholar 

  38. Kuriyama S et al. Expression of a retrovirally transduced gene under control of an internal housekeeping gene promoter does not persist due to methylation and is restored partially by 5-azacytidine treatment Gene Therapy 1998 5: 1299–1305

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

SJ Forbes is a Wellcome Research Training Fellow. Y Takeuchi (The Institute of Cancer Research, London) kindly supplied the TELCeB/AF-7 amphotropic virus producer cell line.

Author information

Authors and Affiliations

  1. Department of Gastroenterology, St Mary's Hospital, London, UK

    S J Forbes

  2. Gene Therapy Group, Imperial College School of Medicine, London, UK

    M Themis & C Coutelle

  3. Histopathology Department, Hammersmith Hospital, London, UK

    M R Alison

  4. Snow Brand Milk Products Co Ltd, Tochigi, Japan

    A Shiota & T Kobayashi

  5. Department of Hepatology, The Royal Free Hospital, London, UK

    H J F Hodgson

Authors
  1. S J Forbes
    View author publications

    Search author on:PubMed Google Scholar

  2. M Themis
    View author publications

    Search author on:PubMed Google Scholar

  3. M R Alison
    View author publications

    Search author on:PubMed Google Scholar

  4. A Shiota
    View author publications

    Search author on:PubMed Google Scholar

  5. T Kobayashi
    View author publications

    Search author on:PubMed Google Scholar

  6. C Coutelle
    View author publications

    Search author on:PubMed Google Scholar

  7. H J F Hodgson
    View author publications

    Search author on:PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Forbes, S., Themis, M., Alison, M. et al. Tri-iodothyronine and a deleted form of hepatocyte growth factor act synergistically to enhance liver proliferation and enable in vivo retroviral gene transfer via the peripheral venous system. Gene Ther 7, 784–789 (2000). https://doi.org/10.1038/sj.gt.3301143

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/sj.gt.3301143

Keywords

This article is cited by

Search

Advanced search

Quick links